GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Relief Therapeutics Holding SA (XSWX:RLF) » Definitions » 3-Year EPS without NRI Growth Rate

Relief Therapeutics Holding (XSWX:RLF) 3-Year EPS without NRI Growth Rate : 22.10% (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Relief Therapeutics Holding 3-Year EPS without NRI Growth Rate?

Relief Therapeutics Holding's EPS without NRI for the six months ended in Dec. 2023 was CHF-0.50.

During the past 3 years, the average EPS without NRI Growth Rate was 22.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was -77.80% per year. During the past 10 years, the average EPS without NRI Growth Rate was 3.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Relief Therapeutics Holding was 80.50% per year. The lowest was -221.00% per year. And the median was 14.15% per year.


Competitive Comparison of Relief Therapeutics Holding's 3-Year EPS without NRI Growth Rate

For the Biotechnology subindustry, Relief Therapeutics Holding's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Relief Therapeutics Holding's 3-Year EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Relief Therapeutics Holding's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Relief Therapeutics Holding's 3-Year EPS without NRI Growth Rate falls into.



Relief Therapeutics Holding 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Relief Therapeutics Holding  (XSWX:RLF) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Relief Therapeutics Holding 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Relief Therapeutics Holding's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Relief Therapeutics Holding (XSWX:RLF) Business Description

Traded in Other Exchanges
Address
Avenue de Secheron 15, Fondation EIP, Batiment, Geneva, CHE, CH-1202
Relief Therapeutics Holding SA is engaged in the research, development, and commercialization of biopharmaceutical products. It mainly develops drugs of natural human origin. It has a focus on commercial products and the development program pipeline is focused on three main areas: rare genetic, metabolic disorders, rare connective tissue disorders, and rare lung diseases. Geographically group generates the majority of its revenue from Europe.

Relief Therapeutics Holding (XSWX:RLF) Headlines

No Headlines